Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
äŒæ¥ã³ãŒãPFE
äŒç€ŸåPfizer Inc
äžå Žæ¥Feb 22, 2080
æé«çµå¶è²¬ä»»è
ãCEOãBourla (Albert)
åŸæ¥å¡æ°81000
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Feb 22
æ¬ç€Ÿæåšå°66 Hudson Boulevard East
éœåžNEW YORK
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·10001-2192
é»è©±çªå·12127332323
ãŠã§ããµã€ãhttps://www.pfizer.com/
äŒæ¥ã³ãŒãPFE
äžå Žæ¥Feb 22, 2080
æé«çµå¶è²¬ä»»è
ãCEOãBourla (Albert)